Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis
David-Axel Laplaud
,
Romain Casey
,
Laetitia Barbin
,
Marc Debouverie
,
Jerome de Sèze
et al.
Journal articles
inserm-02289153v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system
Camille Sabathé
,
Romain Casey
,
Sandra Vukusic
,
Emmanuelle Leray
,
Guillaume Mathey
et al.
Journal articles
hal-04086418v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study
Laetitia Barbin
,
Chloé Rousseau
,
Natacha Jousset
,
Romain Casey
,
Marc Debouverie
et al.
Journal articles
hal-01299977v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosis
F Lejeune
,
A Chatton
,
D-A Laplaud
,
E Le Page
,
S Wiertlewski
et al.
Journal articles
hal-03169764v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Long‐term effect of first‐line injectable multiple sclerosis treatments: input of a time‐dependent propensity score
Mathilde Lefort
,
Yohann Foucher
,
Rémi Lenain
,
Sandra Vukusic
,
Gilles Edan
et al.
Journal articles
hal-02979802v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Comparative efficacyof fingolimod versus natalizumab in multiple sclerosis: a prospective multicenter observational study
D. A. Laplaud
,
L. Barbin
,
Chloé Rousseau
,
N. Jousset
,
Romain Casey
et al.
Multiple Sclerosis Journal , 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.62--63
Journal articles
hal-01259392v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Horizontal mixture model for competing risks: a method used in waitlisted renal transplant candidates
Katy Trébern-Launay
,
Michèle Kessler
,
S. Bayat-Makoei
,
Anne-Hélène Quérard
,
Serge Briançon
et al.
Journal articles
inserm-02153825v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Predictive medicine in multiple sclerosis: A systematic review
Julie Havas
,
Emmanuelle Leray
,
Fabien Rollot
,
Romain Casey
,
Laure Michel
et al.
Journal articles
hal-02470973v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
G-computation, propensity score-based methods, and targeted maximum likelihood estimator for causal inference with different covariates sets: a comparative simulation study
Arthur Chatton
,
Florent Le Borgne
,
Clémence Leyrat
,
Florence Gillaizeau
,
Chloé Rousseau
et al.
Journal articles
hal-02884657v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Baseline characteristics of the first patients included in the OFSEP high definition cohort and relationship between quality of life and patients' characteristics
Romain Casey
,
I. El-Bahi
,
F. Rollot
,
Francis Guillemin
,
D. -A. Laplaud
et al.
Journal articles
hal-02363488v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Long-term effect of interferon and Glatiramer acetate in real-world settings use on multiple sclerosis disability progression: Input of time-dependent propensity score
Mathilde Lefort
,
Yohann Foucher
,
Rémi Lenain
,
Sandra Vukusic
,
Gilles Edan
et al.
Pharmacoepidemiology and Drug Safety , 2019, 28, pp.217-218
Journal articles
hal-02302564v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
The OFSEP high definition cohort to prognosticate the evolution of multiple sclerosis at clinical key steps of the disease
Romain Casey
,
Francis Guillemin
,
D. A. Laplaud
,
Emmanuelle Leray
,
J. Epstein
et al.
Journal articles
hal-01939727v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Improving the decision to switch from first to second-line therapy in MS: a dynamic scoring system
C. Sabathe
,
Romain Casey
,
S. Vukusic
,
Emmanuelle Leray
,
G. Mathey
et al.
Journal articles
hal-03464227v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More